When and why should the pharmaceutical industry use NIR chemical imaging?
| Publicado en: | Pharmaceutical Technology Europe Vol. 22; no. 5; pp. 30 - 33 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
May2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108045763&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108045763 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: May2010 vid: 22 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108045763 2011972151 108045763 ppf: 30 ppct: 3 formats: fmt: @attributes: type: P tig: atl: When and why should the pharmaceutical industry use NIR chemical imaging? aug: au: Dubois, Janie affil: Product Manager Analytical Imaging in the Americas, Malvern instruments sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|